Anti-MDA5 (Melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia

Japanese Journal of Clinical Immunology

Volumn 36, Issue 2, 2013, Pages 71-76

  Nakashima, Ran ^a   Mimori, Tsuneyo ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti MDA5 antibody; Dermatomyositis; Ferritin; Interstitial pneumonia; Macrophage

Indexed keywords

EID: 84929412811     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.36.71     Document Type: Review

References (17)

1. Sato S, Hirakata M, Kuwana M, et al.: Au-toantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52: 1571-1576, 2005.
2. Sato S, Hoshino K, Satoh T, et al.: RNA heli-case encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 60: 2193-2200, 2009.
3. Nakashima R, Imura Y, Kobayashi S, et al.: The RIG-I-like receptor IFIH1/MDA5 is a der-matomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 49: 433-440, 2010.
4. Kato H, Takeuchi O, Sato S, et al.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441: 101-105, 2006.
5. Nawata Y, Kurasawa K, Takabayashi K, et al.: Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol. 26: 1527-1533, 1999.
6. Christensen ML, Pachman LM, Schneiderman R, et al.: Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyosi-tis. Arthritis Rheum. 29: 1365-1370, 1986.
7. Gono T, Kawaguchi Y, Satoh T, et al.: Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxfor). 49: 1713-1719, 2010.
8. Hoshino K, Muro Y, Sugiura K, et al.: Anti-MDA5 and anti-TIFl-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford). 49: 1726-1733, 2010.
9. Fiorentino D, Chung L, Zwerner J, et al.: The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-14): a retrospective study. J Am Acad Dermatol. 65: 25-34, 2011.
10. Gono T, Kawaguchi Y, Ozeki E, et al.: Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol. 21: 223-237, 2011.
11. Tanizawa K, Handa T, Nakashima R, et al.: HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med. 105: 1380-1387, 2011.
12. Gono T, Sato S, Kawaguchi Y, et al.: Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology {Oxford). 51: 1563-1570, 2012.
13. Gono T, Miyake K, Kawaguchi Y, et al.: Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. Rheumatology {Oxford). 51: 1336-1338, 2012.
14. Nagasaka K, Masayoshi H, Matsuto T.: Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneu-monitits associated with dermatomyositis. Modern Rheumatology. 13: 231-238, 2003.
15. Kotani T, Takeuchi T, Makino S, et al.: Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia. Clin Rheumatol. 30: 1021-1028, 2011.
16. Ozawa Y, Kurosaka D, Yokoyama T, Tajima N.: [Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia]. Ryumachi. 40: 798-809, 2000.
17. Kameda H, Nagasawa H, Ogawa H, et al.: Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cy-clophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol. 32: 1719-1726, 2005.